
News|Slideshows|September 2, 2020
Considering Aspirin: 8 Questions on Primary CVD Prevention
Author(s)Aparna Sajja, MD , Seth Martin, MD, MHS
The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.
Advertisement
Remember ARRIVE, ASCEND, and ASPREE–the 3 pivotal randomized controlled trials conducted in nearly 50,000 patients in a variety of possible scenarios that changed the place of aspirin in primary cardiovascular disease prevention for good?
Try this 8-question quiz as a refresher on the study outcomes, the recommendations and patient selection for aspirin use in primary prevention of CVD.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
Topline Phase 2 Data Show Roflumilast Cream Improves Atopic Dermatitis in Infants as Young as 3 Months
2
Icotrokinra Outperforms Advanced Oral Psoriasis Treatments, Matches IL-23 Injectables in Achieving Complete Skin Clearance: Maui Derm 2026
3
FDA Issues Complete Response Letter to Dibutepinephrine (Anaphylm) Sublingual Film for Anaphylaxis
4
First Oral Film Treatment for Erectile Dysfunction in Men Gains FDA Approval
5
































































































































